We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Continues to Defend Zohydro Approval, State Prosecutors Criticize
FDA Continues to Defend Zohydro Approval, State Prosecutors Criticize
As more critics of the FDA’s approval of the painkiller Zohydro ER come forward, the agency says it will not limit approval of new opioid painkillers to those with abuse-deterrent properties.